Molecular Therapies; Dr. David Segal
Is it possible to “turn on” or express the UBE3A gene? Dr. David Segal from the University of California Davis talks about the FIRE funded project his la
Is it possible to “turn on” or express the UBE3A gene? Dr. David Segal from the University of California Davis talks about the FIRE funded project his la
“It has been our hope from day one that the pharmaceutical industry would recognize the promise for developing therapeutics for Angelman Syndrome, we are t
Ovid Therapeutics announces the first ever sponsored clinical trial for Angelman Syndrome. You first heard about Gabaxadol from Dr. Matthew During at the FAS
This International Angelman Day. The goal is to raise awareness of Angelman syndrome worldwide, mobilize people to action, encourage fundraising, promote r
What do you do when you are told your child has a rare and debilitating condition and that the science suggests it can be treated or cured, but the researche
The Federal Government’s Combined Federal Campaign (CFC) season has kicked off and FAST; the Foundation for Angelman Syndrome Therapeutics (CFC #5105
By Jason Berkley It’s hard to believe that it has almost been a year since the First Jamie Berkley Memorial Tournament. To say I felt overwhelmed plan
We are pleased to announce that the Foundation for Angelman Syndrome Therapeutics has been approved to be included on the Combined Federal Campaign (CFC) Ch
On May 11th in Castle Rock, Colorado, approximately 400 participants came out for the first-ever “Moms Rock 5K” for FAST! A virtual run was also held w
My name is Alex McFee; I am a senior at Western Michigan University and am an active member of my sorority Sigma Kappa. Each year for Greek Week the frater